FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail
April 03, 2023 at 11:11 AM EDT
The decision reverses an administrative judge's ruling that dismissed the FTC's initial challenge of Illumina's $7.1 billion Grail deal.
